Scientists conducted the first pilot study in humans to observe the impact of the bacteria Akkermansia. Results: the bacterium limits the increase of several risk factors for cardiovascular diseases, moderates the progression of pre-diabetes and reduces cholesterol levels in humans. A major discovery since one in two individuals is overweight and cardiovascular risk factors. Next step? Researchers plan larger-scale tests and the commercialization of the bacteria.
This post was originally published on this site
media.net, 8CUUP9999, DIRECT rubiconproject.com, 19398, DIRECT, 0bfd66d529a55807 rubiconproject.com, 19398, RESELLER, 0bfd66d529a55807 pubmatic.com, 157599, DIRECT, 5d62403b186f2ace pubmatic.com, 157599, RESELLER, 5d62403b186f2ace openx.com, 537100188, RESELLER, 6a698e2ec38604c6 google.com, pub-7439041255533808, RESELLER, f08c47fec0942fa0 districtm.io, 100600, DIRECT rubiconproject.com, 17054, RESELLER pubmatic.com, 156181, RESELLER spotxchange.com, 211156, RESELLER, 7842df1d2fe2db34 spotx.tv, 211156, RESELLER, 7842df1d2fe2db34